OTC Markets Group Welcomes PetVivo Holdings Inc. to OTCQX
OTC Markets Group (OTCQX: OTCM) announced that PetVivo Holdings Inc. (OTCQX: PETV), an emerging biomedical device company, has qualified to trade on the OTCQX® Best Market, upgrading from the OTCQB® Venture Market.
The upgrade represents a significant milestone for PetVivo, as the OTCQX Market is designed for established companies meeting high financial standards, best practice corporate governance, and securities law compliance. CEO John Lai emphasized that this move demonstrates their commitment to transparency and will enhance visibility among U.S. investors while providing greater liquidity.
OTC Markets Group (OTCQX: OTCM) ha annunciato che PetVivo Holdings Inc. (OTCQX: PETV), una società emergente nel settore dei dispositivi biomedicali, ha ottenuto la qualifica per essere quotata sul OTCQX® Best Market, passando dall’OTCQB® Venture Market.
Questo miglioramento rappresenta un traguardo importante per PetVivo, poiché il mercato OTCQX è riservato a società consolidate che soddisfano elevati standard finanziari, pratiche di governance aziendale ottimali e conformità alle normative sui titoli. Il CEO John Lai ha sottolineato che questo passo dimostra il loro impegno per la trasparenza e aumenterà la visibilità tra gli investitori statunitensi, offrendo al contempo una maggiore liquidità.
OTC Markets Group (OTCQX: OTCM) anunció que PetVivo Holdings Inc. (OTCQX: PETV), una empresa emergente de dispositivos biomédicos, ha calificado para cotizar en el OTCQX® Best Market, ascendiendo desde el OTCQB® Venture Market.
Esta mejora representa un hito significativo para PetVivo, ya que el mercado OTCQX está diseñado para compañías consolidadas que cumplen con altos estándares financieros, las mejores prácticas de gobierno corporativo y el cumplimiento de las leyes de valores. El CEO John Lai enfatizó que este movimiento demuestra su compromiso con la transparencia y aumentará la visibilidad entre los inversionistas estadounidenses, además de brindar mayor liquidez.
OTC Markets Group (OTCQX: OTCM)는 신생 바이오메디컬 장비 회사인 PetVivo Holdings Inc. (OTCQX: PETV)가 OTCQB® 벤처 마켓에서 OTCQX® Best Market으로 거래 자격을 승격했다고 발표했습니다.
이번 승격은 PetVivo에게 중요한 이정표로, OTCQX 마켓은 높은 재무 기준, 모범적인 기업 거버넌스 및 증권법 준수를 충족하는 안정된 기업을 위해 설계되었습니다. CEO John Lai는 이번 조치가 투명성에 대한 그들의 의지를 보여주며 미국 투자자들 사이에서 가시성을 높이고 유동성을 향상시킬 것이라고 강조했습니다.
OTC Markets Group (OTCQX : OTCM) a annoncé que PetVivo Holdings Inc. (OTCQX : PETV), une entreprise émergente dans le domaine des dispositifs biomédicaux, a été qualifiée pour être cotée sur le OTCQX® Best Market, passant ainsi du marché OTCQB® Venture Market.
Cette montée en gamme représente une étape importante pour PetVivo, puisque le marché OTCQX est destiné aux entreprises établies respectant des normes financières élevées, une gouvernance d’entreprise exemplaire et la conformité aux lois sur les valeurs mobilières. Le PDG John Lai a souligné que cette démarche témoigne de leur engagement envers la transparence et améliorera la visibilité auprès des investisseurs américains tout en offrant une meilleure liquidité.
OTC Markets Group (OTCQX: OTCM) gab bekannt, dass PetVivo Holdings Inc. (OTCQX: PETV), ein aufstrebendes Unternehmen für biomedizinische Geräte, sich für den Handel am OTCQX® Best Market qualifiziert hat und damit vom OTCQB® Venture Market aufgestiegen ist.
Dieser Aufstieg stellt einen bedeutenden Meilenstein für PetVivo dar, da der OTCQX-Markt für etablierte Unternehmen konzipiert ist, die hohe finanzielle Standards, beste Corporate-Governance-Praktiken und die Einhaltung von Wertpapiergesetzen erfüllen. CEO John Lai betonte, dass dieser Schritt ihr Engagement für Transparenz zeigt und die Sichtbarkeit bei US-Investoren erhöht sowie eine höhere Liquidität bietet.
- Upgrade to OTCQX Best Market indicates higher financial and governance standards
- Enhanced visibility and accessibility for U.S. investors
- Potential for improved trading liquidity
- None.
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced PetVivo Holdings Inc. (OTCQX: PETV), an emerging biomedical device company, has qualified to trade on the OTCQX® Best Market. PetVivo Holdings Inc. upgraded to OTCQX from the OTCQB® Venture Market.
PetVivo Holdings Inc. begins trading today on OTCQX under the symbol “PETV.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.
“Qualifying to trade on the OTCQX Best Market is a significant milestone for our Company,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “This upgrade reflects our continued commitment to transparency, strong corporate governance, and delivering long-term value to our shareholders. Trading on OTCQX will enhance our visibility within the investment community and provide greater liquidity and accessibility for investors as we continue to execute on our strategic growth initiatives.”
About PetVivo Holdings Inc.
PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo"), are based in Edina, Minnesota. It is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for equine and companion animals. PetVivo believes that it can leverage the investments in the human bio-materials and medical device industries to commercialize medical devices and therapeutics to animals in a capital and time efficient way. PetVivo's strategy is to internally develop and/or in-license proprietary products from human medical device companies specifically for use in pets. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.
PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead products SPRYNG™ with OsteoCushion™ technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.
For more information about PetVivo Holdings, Inc. please contact info1@petvivo.com or visit https://petvivo.com/, https://www.petvivoanimalhealth.com/ and https://www.sprynghealth.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our public markets: OTCQX® Best Market, OTCQB® Venture Market, OTCID™ Basic Market and Pink Limited™ Market. Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATS™ are each SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC. To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
